Visual and Anatomical Outcomes of Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration

A retrospective chart review of patients with persistent subretinal and/or intraretinal fluid, despite previous treatment with intravitreal ranibizumab (0.5 mg), who were switched to aflibercept injections, was performed. Treatment was three monthly aflibercept (2 mg) injections followed by dosing o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gharbiya, Magda, Iannetti, Ludovico, Parisi, Francesco, De Vico, Umberto, Mungo, Maria Laura, Marenco, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033502/
https://www.ncbi.nlm.nih.gov/pubmed/24895562
http://dx.doi.org/10.1155/2014/273754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033502/
https://www.ncbi.nlm.nih.gov/pubmed/24895562
http://dx.doi.org/10.1155/2014/273754

Ejemplares similares